Treatment Preferences in Patients With Early Glottic Cancer.

Related Articles

Treatment Preferences in Patients With Early Glottic Cancer.

Ann Otol Rhinol Laryngol. 2017 Dec 01;:3489417749253

Authors: van Loon Y, Hendriksma M, Langeveld TPM, de Jong MA, Baatenburg de Jong RJ, Sjögren EV

Abstract
OBJECTIVE: For early glottic carcinoma, the 2 main treatment modalities are radiotherapy (RT) and transoral CO2 laser microsurgery (TLM). The aim of this study was to investigate treatment preferences and considerations in patients with early glottic carcinoma (T1-T2) who were given a choice between TLM and RT.
SUBJECTS AND METHODS: Patients with early glottic cancer (suspected or confirmed extended T1 or limited T2) were counseled by an ENT-surgeon. A subset of 32 patients was also counseled by a radiotherapist. Treatment choice and considerations were recorded and analyzed.
RESULTS: Of 175 patients, 168 patients (96%) chose TLM, and 7 patients (4%) chose RT. The most common reason for choosing TLM was shorter treatment and more treatment options in case of recurrence. Subanalysis showed that additional counseling by the radiotherapist did not seem to affect our patients' preferences for TLM in this group.
CONCLUSIONS: The majority of patients in our study prefer TLM to RT when given a choice. Reasons given indicate that optimizing future treatment options and practical considerations seemed more important to our patients than primary functional outcome. Further research is needed to study patient-related and physician-related factors to gain more insight into this complicated process of shared decision making.

PMID: 29291278 [PubMed - as supplied by publisher]

http://ift.tt/2CsmB3A